Psoriasis is a multifactorial-chronic-inflammatory skin disease, charac- terized by erythemato-squamous lesions, with a chronic relapsing course and significant systemic comorbidities (arthritis, cardiovascular and metabolic diseases). Erythrodermic psoriasis (EP), has a prevalence of 1% to 2.25% among psoriatic population. EP is characterized by cutaneous redness, tending to purple, scal- ing, edema, pruritus, occasionally exudative lesions and diffuse des- quamation, covering more than 90% of body surface.

Recurrent erythrodermic psoriasis and polycythemia successfully treated with brodalumab / Bernardini, Nicoletta; Skroza, Nevena; Tolino, Ersilia; Mambrin, Alessandra; Balduzzi, Veronica; Marchesiello, Anna; Michelini, Simone; Volpe, Salvatore; Maddalena, Patrizia; Proietti, Ilaria; Potenza, Concetta. - In: DERMATOLOGIC THERAPY. - ISSN 1529-8019. - 33:6(2020). [10.1111/dth.14338]

Recurrent erythrodermic psoriasis and polycythemia successfully treated with brodalumab

Nicoletta Bernardini
;
Nevena Skroza;Ersilia Tolino;Alessandra Mambrin;Salvatore Volpe;Patrizia Maddalena;Ilaria Proietti;Concetta Potenza
2020

Abstract

Psoriasis is a multifactorial-chronic-inflammatory skin disease, charac- terized by erythemato-squamous lesions, with a chronic relapsing course and significant systemic comorbidities (arthritis, cardiovascular and metabolic diseases). Erythrodermic psoriasis (EP), has a prevalence of 1% to 2.25% among psoriatic population. EP is characterized by cutaneous redness, tending to purple, scal- ing, edema, pruritus, occasionally exudative lesions and diffuse des- quamation, covering more than 90% of body surface.
2020
psoriasis; polycythemia; brodalumab
01 Pubblicazione su rivista::01f Lettera, Nota
Recurrent erythrodermic psoriasis and polycythemia successfully treated with brodalumab / Bernardini, Nicoletta; Skroza, Nevena; Tolino, Ersilia; Mambrin, Alessandra; Balduzzi, Veronica; Marchesiello, Anna; Michelini, Simone; Volpe, Salvatore; Maddalena, Patrizia; Proietti, Ilaria; Potenza, Concetta. - In: DERMATOLOGIC THERAPY. - ISSN 1529-8019. - 33:6(2020). [10.1111/dth.14338]
File allegati a questo prodotto
File Dimensione Formato  
Bernardini_Recurrent-erythrodermic-psoriasis_2020.pdf

solo gestori archivio

Note: https://onlinelibrary.wiley.com/doi/10.1111/dth.14338
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 6.11 MB
Formato Adobe PDF
6.11 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1572199
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 7
social impact